Latest Roche Diagnostics Stories
The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW) -
LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical
PORTLAND, Oregon, June 10, 2014 /PRNewswire/ -- According to a new research report by Allied Market Research titled "Global Companion Diagnostic Market (Indications, Technologies
Market Size - $4,476.6 mn in 2013, Market Growth - CAGR of 8.7%, Market Trends - High demand for personalized medicine & genetic testing.
Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer.
GrandViewResearch.com has announced the addition of "Global In-Vitro Diagnostics (IVD) Market Analysis And Segment Forecasts To 2020" Market Research Report to their Database.
Formation of strategic alliance designed to help accelerate advancement of new methods in molecular diagnostics testing and personalized predictive treatment
A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving
DALLAS, May 9, 2014 /PRNewswire/ -- According to the new market research report the "Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology